Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/108908| Title: | Differential expression of breast cancer signature genes following rapamycin treatment |
| Authors: | Petroni, Vanessa Fenech, Anthony G. Saliba, Christian Camilleri Podesta, Marie Therese Baldacchino, Shawn Grech, Godfrey |
| Keywords: | Breast -- Cancer -- Treatment MTOR inhibitors Rapamycin -- Effectiveness Aurora Kinase A MCF-7 cells |
| Issue Date: | 2015 |
| Publisher: | University of Malta. Medical School |
| Citation: | Petroni, V., Fenech, A.G., Saliba, C., Camilleri Podesta, M.T., Baldacchino, S., & Grech, G. (2015). Differential expression of breast cancer signature genes following rapamycin treatment. IX Malta Medical School Conference abstract book, OP3.18. |
| Abstract: | Introduction: Breast cancer is classified into intrinsic molecular subtypes, each relating to predictive prognostic and clinical outcomes. Rapamycin inhibits the mammalian target of rapamycin (mTOR) pathway, which is often deregulated in various types of cancer. mTOR inhibitors are associated with antiproliferation and apoptosis. Aim: Investigating the differential expression of breast cancer signature genes following rapamycin treatment in various breast cancer subtypes. |
| URI: | https://www.um.edu.mt/library/oar/handle/123456789/108908 |
| ISSN: | 18133339 |
| Appears in Collections: | Scholarly Works - FacM&SPat |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Differential expression of breast cancer signature genes following rapamycin treatment 2015.pdf | 80.84 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.